Rat natural killer cell, T cell and macrophage functions after intracerebroventricular injection of SNC 80

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 931-937

  Nowak, Jason E ^a   Gomez Flores, Ricardo ^a   Calderon, Silvia N ^b   Rice, Kenner C ^b   Weber, Richard J ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 HYDROXYBENZYL] N,N DIETHYLBENZAMIDE; 4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; CD4 ANTIGEN; CD8 ANTIGEN; CONCANAVALIN A; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; GAMMA INTERFERON; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; NITRIC OXIDE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HELPER CELL; IMMUNOSTIMULATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MALE; NATURAL KILLER CELL; NEUROIMMUNOLOGY; NEUROMODULATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN CELL; T LYMPHOCYTE ACTIVATION;

ANIMALS; BENZAMIDES; CELL DIVISION; CULTURE MEDIA; FLOW CYTOMETRY; INDICATORS AND REAGENTS; INJECTIONS, INTRAVENTRICULAR; KILLER CELLS, NATURAL; MACROPHAGES; MALE; NITRITES; PIPERAZINES; RATS; RATS, INBRED F344; RECEPTORS, OPIOID, DELTA; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0032439637     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ballantyne JC, Carr DB, Berkey CS, Chalmers TC and Mosteller F (1996) Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer. Reg Anesth 21:542-556.
2. Band LC, Pert A, Williams W, de Costa BR, Rice KC and Weber RJ (1992) Central μ-opioid receptors mediate suppression of natural killer activity in vivo. Prog Neuroendocrinimmunol 5:95-101.
3. Bayer BM, Gastonguay MR and Hernandez MC (1992) Distinction between the in vitro and in vivo inhibitory effects of morphine on lymphocyte proliferation based on agonist sensitivity and naltrexone reversibility. Immunopharmacology 23:117-124.
4. Belkowski SM, Alicea C, Eisenstein TK, Adler MW and Rogers TJ (1995) Inhibition of interleukin-1 and tumor necrosis factor-α synthesis following treatment of macrophages with the kappa opioid agonist U50,488H. J Pharmacol Exp Ther 273:1491-1496.
5. Bilsky EJ, Calderon SN, Wang T, Bernstein RN, Davis P, Hruby VJ, McNutt RW, Rothman RB, Rice KC and Porreca F (1995) SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist. J Pharmacol Exp Ther 273:359-366.
6. Calderon SN, Rothman RB, Porreca F, Flippen-Anderson JL, McNutt RW, Xu H, Smith LE, Bilsky EJ, Davis P and Rice KC (1994) Probes for narcotic receptor mediated phenomena. 19. Synthesis of (+)-4-[(alpha R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N- diethylbenzamide (SNC 80): A highly selective, nonpeptide δ opioid receptor. J Med Chem 37:2125-2128.
7. Carr DJJ and Carpenter GW (1995) Morphine-induced suppression of cytotoxic T lymphocyte activity in alloimmunized mice is not mediated through a naltrindole-sensitive delta opioid receptor. Neuroimmunomodulation 2:44-53.
8. Carr DJ, Carpenter GW, Garza HH, Jr., Baker ML and Gebhardt BM (1995) Cellular mechanisms involved in morphine-mediated suppression of CTL activity. Adv Exp Med Biol 373:131-139.
9. Carr DJJ, Gebhardt BM and Paul D (1993) Alpha adrenergic and mu-2 involved in morphine-induced suppression of splenocyte natural killer activity. J Pharmacol Exp Ther 264:1179-1186.
10. Carr DJJ, Mayo S, Gebhardt B and Porter J (1994) Central α-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity. J Neuroimmunol 53:53-63.
11. Chambers WH, Vujanovic NL, DeLeo AB, Olszowy MW, Herberman RB and Hiserodt JC (1989) Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. J Exp Med 169:1373-1389.
12. Chang KJ, Rigdon GC, Howard JL and McNutt RW (1993) A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. J Pharmacol Exp Ther 267:852-857.
13. Fecho K, Maslonek KA, Dyhstra LA and Lysle DT (1996) Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther 276:626-636.
14. Flores LR, Wahl SM and Bayer BM (1995) Mechanisms of morphine-induced immunosuppression: Effect of acute morphine administration on lymphocyte trafficking. J Pharmacol Exp Ther 272:1246-1251.
15. Flores LR, Dretchen KL and Bayer BM (1996) Potential role of the autonomic nervous system in the immunosuppressive effects of acute morphine administration. Eur J Pharmacol 318:437-446.
16. Gomez-Flores R, Tamez-Guerra R, Tucker SD and Mehta RT (1997a) Bidirectional effects of IFN-γ on growth of Mycobacterium avium complex in murine peritoneal macrophages. J Cytokine Interferon Res 17:331-336.
17. Gomez-Flores R, Rodriguez-Padilla C, Mehta RT, Galan-Wong L, Mendoza-Gamboa E and Tamez-Guerra R (1997b) Nitric oxide and TNF-α production by murine peritoneal macrophages activated with a novel 20-kDa protein isolated from Bacillus thuringiensis var. thuringiensis parasporal bodies. J Immunol 158:3796-3799.
18. Hambrook JM, Morgan BA, Rance MJ and Smith CF (1976) Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature 262:782-783.
19. Hucklebridge FH, Hudspith BN, Lydyar PM and Brostoff J (1990) Stimulation of human peripheral lymphocytes by methionine enkephalin and delta-selective opioid analogues. Immunopharmacology 19:87-91.
20. Iuvone T, Capasso A, D'Acquisto F and Carnuccio R (1995) Opioids inhibit the induction of nitric oxide synthase in J774 macrophages. Biochem Biophys Res Commun 212:975-980.
21. Jonsdottir IH, Johansson C, Asea A, Hellstrand K, Thorén P and Hoffmann P (1996) Chronic intracerebroventricular administration of β-endorphin augments natural killer cell cytotoxicity in rats. Regul Pept 62:113-118.
22. Kaldjian EP, Chen GH and Cease KB (1992) Enhancement of lymphocyte proliferation assays by use of serum-free medium. J Immunol Methods 147:189-195.
23. Lysle DT, Coussons ME, Watts VJ, Bennett EH, Dykstra LA (1993) Morphine-induced alterations of immune status: Dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther 265:1071-1078.
24. Lysle DT, Hoffman KE and Dykstra LA (1996) Evidence for the involvement of the caudal region of the periaqueductal gray in a subset of morphine-induced alterations of immune status. J Pharmacol Exp Ther 277:1533-1540.
25. Panerai AE, Manfredi B, Granucci F and Sacerdote P (1994) The β-endorphin inhibition of mitogen-induced splenocytes proliferation is mediated by central and peripheral paracrine/autocrine effects of the opioid. J Neuroimmunol 58:71-76.
26. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
27. Pert CB and Snyder SH (1973) Opiate receptor: demonstration in nervous tissue. Science 179:1011-1014.
28. Provinciali M, Di Stefano G, Stronati S, Raffaeli W, Pari G and Fabris N (1996) Role of prolactin in the modulation of NK and LAK cell activity after short- or long-term morphine administration in neoplastic patients. Int J Immunopharmacol 18:577-586.
29. Rapaka RS and Porreca F (1991) Development of delta opioid peptides as nonaddicting analgesics. Pharm Res 8:1-8.
30. Rojavin M, Szabo I, Bussiere JL, Rogers TJ, Adler MW and Eisenstein TK (1993) Morphine treatment in vitro or in vivo decreases phagocytic functions of murine macrophages. Life Sci 53:997-1006.
31. Scott M and Carr DJJ (1996) Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner. J Pharmacol Exp Ther 278:980-988.
32. Shavit Y, Depaulis A, Martin FC, Terman GW, Pechnick RN, Zane CJ, Gale RP and Liebeskind JC (1986) Involvement of brain opiate receptors in the immune-suppressive effect of morhine. Proc Natl Acad Sci USA 83:7114-7117.
33. Simon EJ, Hiller JM and Edelman I (1973) Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate. Proc Natl Acad Sci USA 70:1947-1949.
34. Terenius L (1973) Stereospecific uptake of narcotic analgesics by a subcellular fraction of the guinea-pig ileum. A preliminary communication. Ups J Med Sci 78:150-152.
35. Tubaro E, Santiangeli C, Belogi L, Borelli G, Cavallo G, Croce C and Avico U (1987) Methadone vs morphine: comparison of their effect on phagocytic functions. Int J Immunopharmacol 9:79-88.
36. Weber RJ and Pert A (1989) The periaqueductal gray matter mediates opiate-induced immunosuppression. Science 245:188-190.
37. Williams W, Rice KC and Weber RJ (1991) Nonpeptide opioids: in vivo effects on the immune system. NIDA Res Monogr 105:404-407.
38. Zaki PA, Bilsky EJ, Vanderah TW, Lai J, Evans CJ and Porreca F (1996) Opioid receptor types and subtypes: the delta receptor as a model. Annu Rev Pharmacol Toxicol 36:379-401.